Quimioterapia intratecal: percepções e significados atribuídos por pacientes com câncer hematológico

Soares, Thais Almeida; Oliveira, Leonardo Rodrigues de; Bracarence, Carolina Feliciana; Costa, Nara dos Santos; Moraes-Souza, Helio; Contim, Divanice.
Rev. enferm. UERJ ; 27: e44294, jan.-dez. 2019.
Artículo en Portugués | LILACS, BDENF - enfermagem (Brasil) | ID: biblio-1097362

Documentos relacionados

  1. Developing a classification of hematologic neoplasms in the era of precision medicine.
  2. DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies.
  3. Frequency of subclinical herpes zoster in pediatric hematology-oncology patients receiving chemotherapy: A retrospective cohort analysis.
  4. Minority groups underrepresented in hematologic cancer trials.
  5. Inherited blood cancer predisposition through altered transcription elongation.
  6. Can Peripherally Inserted Central Catheters Be Safely Placed in Patients with Cancer Receiving Chemotherapy? A Retrospective Study of Almost 400,000 Catheter-Days.
  7. Subgroup analysis in haematologic malignancies phase III clinical trials: A systematic review.
  8. Telomerase inhibition in haematological neoplasms-are we ready for primetime?
  9. Guiding the global evolution of cytogenetic testing for hematologic malignancies.
  10. Germline predisposition to haematological malignancies: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar and the NHS England Haematological Oncology Working Group.